Tumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcome
about
sameAs
Promotion of importin alpha-mediated nuclear import by the phosphorylation-dependent binding of cargo protein to 14-3-3Phosphorylation and interaction of myopodin by integrin-link kinase lead to suppression of cell growth and motility in prostate cancer cellsExpression of myopodin induces suppression of tumor growth and metastasisMyopodin isoforms alter the chemokinetic response of PC3 cells in response to different migration stimuli via differential effects on Rho-ROCK signaling pathwaysSynaptopodin-2 induces assembly of peripheral actin bundles and immature focal adhesions to promote lamellipodia formation and prostate cancer cell migration.Identification of a subunit of NADH-dehydrogenase as a p49/STRAP-binding protein.Synaptopodin family of natively unfolded, actin binding proteins: physical properties and potential biological functions.Identification of six new susceptibility loci for invasive epithelial ovarian cancer.Development and Validation of a Gene-Based Model for Outcome Prediction in Germ Cell Tumors Using a Combined Genomic and Expression Profiling Approach.The actin binding protein, fesselin, is a member of the synaptopodin family.Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumorsIn vitro characterization of native mammalian smooth-muscle protein synaptopodin 2.Hypermethylation in bladder cancer: biological pathways and translational applications.A monopartite nuclear localization sequence regulates nuclear targeting of the actin binding protein myopodin.Chaperone-assisted proteostasis is essential for mechanotransduction in mammalian cells.Myopodin is an F-actin bundling protein with multiple independent actin-binding regions.Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.Association of a common variant of SYNPO2 gene with increased risk of serous epithelial ovarian cancer.Myopodin methylation is a prognostic biomarker and predicts antiangiogenic response in advanced kidney cancer.Diagnostic and prognostic utility of methylation and protein expression patterns of myopodin in colon cancer.
P2860
Q24301742-92B05D66-D4E9-4307-A8A7-871CC48767AAQ24305936-7E6E4F8F-DFD6-48F4-B327-DC8815A0B4C3Q24672315-050C4C01-810D-4F02-B691-060C7F2EE92EQ28910358-5F516880-B136-4375-A4A7-F3B2120E5170Q30655968-DFD77A36-FCAF-4102-9179-7A2A49DAA1A8Q33317099-EAF28B94-6CD3-4BE6-B37D-E24D6A2BD8F5Q33639599-DF2F09E2-7A8D-4346-A771-975586AB7DC4Q35541663-43A74438-D2B6-48A8-898A-8EA369DE4890Q35857034-50D6DDC7-87D9-497E-AB02-7B9EDBBCE538Q36755886-981F001F-19EE-4F3C-961F-4D92ACA16728Q36836098-0491F20A-3CBF-4CD9-81BF-9319DD90E343Q37148915-822D8E1F-BD5A-45AF-A724-CFB052619FF5Q37978544-13972673-59E8-441D-BB09-82E3B666DF5EQ40347310-E237899C-AB24-4F8A-A072-D58C8EA18130Q42273479-6113F3B0-713B-4350-8A4C-A63E36D7334BQ43813236-F6C992F5-A0F6-44C7-8626-31712C6AB2B9Q47678044-5108B98B-8868-45BF-A813-5756CF2774BCQ50992801-65990C57-045E-4D64-A166-98618AC98EBCQ51534795-BDDC8571-9E1C-410B-9C9B-CE8A4EBEAD7CQ54328709-754CA913-08B4-4DF9-AEC3-76B71A022C4A
P2860
Tumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcome
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Tumor suppressor role for myop ...... and predicts clinical outcome
@ast
Tumor suppressor role for myop ...... and predicts clinical outcome
@en
Tumor suppressor role for myop ...... and predicts clinical outcome
@nl
type
label
Tumor suppressor role for myop ...... and predicts clinical outcome
@ast
Tumor suppressor role for myop ...... and predicts clinical outcome
@en
Tumor suppressor role for myop ...... and predicts clinical outcome
@nl
prefLabel
Tumor suppressor role for myop ...... and predicts clinical outcome
@ast
Tumor suppressor role for myop ...... and predicts clinical outcome
@en
Tumor suppressor role for myop ...... and predicts clinical outcome
@nl
P2093
P2860
P356
P1433
P1476
Tumor suppressor role for myop ...... and predicts clinical outcome
@en
P2093
Elizabeth Charytonowicz
Karin Schwarz
Marta Sanchez-Carbayo
Peter Mundel
P2860
P2888
P304
P356
10.1038/SJ.ONC.1206616
P407
P577
2003-08-14T00:00:00Z
P5875
P6179
1001115630